financetom
Business
financetom
/
Business
/
Nasdaq Offers to Repurchase up to $200 Million in Outstanding Debt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nasdaq Offers to Repurchase up to $200 Million in Outstanding Debt
Feb 10, 2025 6:04 AM

08:41 AM EST, 02/10/2025 (MT Newswires) -- Nasdaq (NDAQ) said Monday it is offering to purchase up to $200 million of its outstanding notes in order to reduce its overall debt burden.

The notes include up to $40 million worth of 5.350% senior notes due 2028, up to $50 million worth of 5.550% senior notes due 2034, and up to $110 million worth of its 3.950% senior notes due 2052, the company said.

The tender offers will expire March 11, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Before Trump's return, some top U.S. firms had already gone cold on diversity pledges
Before Trump's return, some top U.S. firms had already gone cold on diversity pledges
Jan 27, 2025
LONDON (Reuters) - Some large U.S. companies had made limited progress in promoting women and were diluting or abandoning equal opportunity initiatives even before President Donald Trump launched last week a nationwide campaign to scrap them, underscoring a shift in corporate priorities. Shortly after taking office on Jan. 20, Trump issued sweeping executive orders to dismantle diversity, equity and inclusion...
Pfizer to Pay $59.7 Million to Resolve Biohaven's Alleged Kickback Scheme for Nurtec ODT
Pfizer to Pay $59.7 Million to Resolve Biohaven's Alleged Kickback Scheme for Nurtec ODT
Jan 27, 2025
07:01 AM EST, 01/27/2025 (MT Newswires) -- Pfizer ( PFE ) agreed to pay about $59.7 million to settle allegations that Biohaven Pharmaceutical Holding, before being acquired by Pfizer ( PFE ), defrauded several US health care programs by paying kickbacks to doctors to drive prescriptions of its Nurtec ODT drug for migraine, the US Department of Justice said Friday....
Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review
Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review
Jan 27, 2025
07:02 AM EST, 01/27/2025 (MT Newswires) -- Alvotech ( ALVO ) and Teva Pharmaceutical (TEVA) said Monday that the US Food and Drug Administration has accepted to review their biologics license applications for AVT05 to treat inflammatory conditions. The review process is expected to be completed in Q4. This comes after the achievement of positive top-line results in April 2024...
Bank of Hawaii Q4 Earnings, Revenue Increase
Bank of Hawaii Q4 Earnings, Revenue Increase
Jan 27, 2025
07:00 AM EST, 01/27/2025 (MT Newswires) -- Bank of Hawaii ( BOH ) reported Q4 earnings Monday of $0.85 per diluted share, up from $0.72 a year earlier. Analysts polled by FactSet expected $0.83. Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and total non-interest income, was $163.2 million, up from $158.1 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved